Clinical Trial Update: Effect on Migraine Frequency of Combined Anti-oxidant Therapy: The MIGRANT Study. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effect of combined anti-oxidant therapy on migraine frequency. The current status of the study is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Snippet

Sponsor: University of Notre Dame Australia | Conditions: Migraine, Headaches | Phase 3 | Status: UNKNOWN